March 16th, 2015
Sripal Bangalore discusses his observational study comparing CABG with everolimus-eluting stent PCI in patients with multivessel coronary disease, alongside findings from the BEST randomized trial.
August 19th, 2014
Harlan Krumholz interviews Sripal Bangalore about his research group’s study of the prognostic value of non-fasting lipid panels.
October 2nd, 2012
Dr. Sripal Bangalore discusses his JAMA study, which found beta-blocker use was not associated with a reduced rate of cardiovascular eventsin patients who have, or are at risk for, stable coronary artery disease.